Médecine et sciences de la vie
Thromboxanes
100%
N-terbutyl-N'-(2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl)urea
89%
Thromboxane Receptors
83%
SARS Virus
71%
Thromboxane A2
62%
Dabigatran
55%
Anticoagulants
55%
Thrombin
45%
Pharmacology
40%
Blood Platelets
37%
Extracellular Vesicles
37%
Rivaroxaban
36%
Thrombosis
35%
Hemostasis
33%
Carbonic Anhydrase Inhibitors
31%
Activated Protein C Resistance
30%
Prostaglandin H2 Receptors Thromboxane A2
29%
Torsemide
27%
Cyclooxygenase 2 Inhibitors
27%
Platelet Aggregation
26%
Swine
26%
Urea
24%
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
24%
BM 567
24%
Protein-Tyrosine Kinases
23%
Heparin
22%
Paroxysmal Hemoglobinuria
22%
Antibodies
22%
Hemorrhage
22%
Atherosclerosis
20%
Epoprostenol
20%
edoxaban
20%
Sulfonamides
20%
Prostaglandin-Endoperoxide Synthases
20%
Prothrombin Time
20%
Pharmaceutical Preparations
19%
Neutralizing Antibodies
19%
Coronavirus
19%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
18%
Carbonic Anhydrases
18%
Thrombocytopenia
18%
Arachidonic Acid
17%
ponatinib
17%
Vaccines
17%
Carbonic Anhydrase IX
16%
Therapeutics
16%
Blood Vessels
15%
eculizumab
15%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
15%
Immunoglobulin G
15%
composés chimiques
Thromboxane
64%
Thromboxane Synthase Inhibitor
60%
Thromboxane A2
49%
Thromboxanes A
49%
Anticoagulant Agent
46%
Thromboxane A2 Receptor Blocking Agent
41%
Torasemide
36%
Antagonist
29%
Arachidonic Acid
28%
Sulfonamide
22%
Drug
22%
Coagulation
21%
Prostanoid
20%
Agent Interacting With Transmitter, Hormone or Drug Receptor
20%
Thromboxane Receptor Blocking Agent
17%
Dose
16%
Thrombin
15%
Plasma
15%
Hemodynamic
15%
Rivaroxaban
14%
Dabigatran Etexilate
14%
Dabigatran
13%
Nonsteroid Antiinflammatory Agent
12%
Nanoparticle
12%
Urea
12%
Thromboxane A2 Receptor Stimulating Agent
11%
Antithrombocytic Agent
11%
Resistance
11%
Nanomaterial
11%
Anticonvulsant
11%
Structure-Activity Relationship
11%
Clearance
10%
Procoagulant
10%
Molecular Modeling
10%
Protein C
10%
Contraceptive Agent
9%
Nimesulide
9%
Convulsion
9%
Thrombotic
9%
Leukotriene
8%
Heparin
8%
Time
8%
Biosynthesis
7%
Celecoxib
7%
Molecule
7%
Warfarin
7%
Cyclooxygenase 2 Inhibitor
7%
Safety
6%